Bisphosphonate Binding Affinity Affects Drug Distribution in Both Intracortical and Trabecular Bone of Rabbits

The relationship between the chemistry and biological activity of the bisphosphonates

(2011) Frank H. Ebetino et al.   BONE

Synthesis and Characterization of Novel Fluorescent Nitrogen-Containing Bisphosphonate Imaging Probes for Bone Active Drugs

(2011) Shuting Sun et al.   PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS

Novel actions of bisphosphonates in bone: Preservation of osteoblast and osteocyte viability

(2010) Teresita Bellido et al.   BONE

Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females

(2010) Robert R. Recker et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Near-infrared fluorescent probe traces bisphosphonate delivery and retention in vivo

(2010) Kenneth M Kozloff et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Molecular Optical Imaging with Radioactive Probes

(2010) Hongguang Liu et al.   PLoS One

The differential distribution in vivo of fluorescently-labeled bisphosphonate analogues with different mineral affinity to bone surfaces

(2009) A. Boyde et al.   BONE

Bone mineral affinity influences the distribution of a bisphosphonate and a lower affinity analogue in vivo

(2009) A.J. Roelofs et al.   BONE

Risedronate reduces intracortical porosity in women with osteoporosis

(2009) Babul Borah et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs

(2009) Matthew R Allen et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo

(2009) Anke J Roelofs et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Fluorescently Labeled Risedronate and Related Analogues: “Magic Linker” Synthesis

(2008) Boris A. Kashemirov et al.   BIOCONJUGATE CHEMISTRY

Alendronate Reduces Bone Toughness of Ribs without Significantly Increasing Microdamage Accumulation in Dogs Following 3 Years of Daily Treatment

(2008) Matthew R. Allen et al.   CALCIFIED TISSUE INTERNATIONAL

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy

(2008) R. G. G. Russell et al.   OSTEOPOROSIS INTERNATIONAL